GREAT AT SMALL THINGS

0

GeneCorner plasmid details

Last data update: 24 January 2024 16:39 CET

Plasmid name: pREP4 (LMBP 2649)

Add to cart

New search Print data sheet
Price category: Cat. 1 (cf. price list)
Status: GeneCorner core plasmid
GeneCorner sequence: p2649.gb (View with Genome Compiler)
p2649.txt
p2649.pdf
Sequence
analysis results
Genecorner:

-

Cloned DNA: Escherichia coli lac repressor gene (lacI)
Promoter: Escherichia coli lac repressor promoter (lacI)
Ribosome
binding site:
-
Terminator: -
Selection marker: Neomycin (neo; kanamycin (kan))
Replicon: Escherichia coli plasmid p15A origin
Copy number: Low copy number
Host range: Escherichia coli
Parental clone: pACYC184
Further information: Because of the presence of the lacI gene, multiple copies of pREP4 ensure high levels of lac repressor and tight regulation of protein expression.
Due to mutations in the ribosome binding site of the neomycin resistance gene, pREP4 requires only 25 μg/ml of kanamycin for selection.
The plasmid is compatible with all plasmids carrying the ColE1 origin of replication.
The nucleotide sequence of the vector corresponds with the EMBL Nucleotide Sequence Database accession number A18755.1.
EMBL Accession number: A18755.1, view at EMBL, GenBank, DDBJ
Latest sequence update: 25/05/1993
Authenticity test: Restriction enzyme pattern analysed at GeneCorner: HindIII, SalI and SphI.
Class: Recombinant plasmid
Type: Plasmid
History of deposit: This plasmid was deposited by F. Hoffmann - La Roche LTD(1).
(1) Basel, Switserland
Plasmid reference: -
Restricted distribution: - BCCM MTA
Distributed as: H/P active culture or plasmid DNA
Host for distribution: Escherichia coli K12 M15
Host reference: Beckwith et al., Mol. Biol. 8 (1964), 427-430 [PMID: 14168696]
Cultivation medium: LB-Lennox + kanamycin (25 μg/ml)
Cultivation temperature: 37°C
Biosafety level: L1
Other culture collection numbers: -

Refer in your Materials and Methods:

pREP4 (LMBP 2649) is available at BCCM/GeneCorner. This plasmid was deposited by F. Hoffmann - La Roche LTD.

Note: Up-to-date, validated data are enclosed with the biological material. Nevertheless, these data are a snapshot at a given moment; further updates are always possible.

New search